Glutamate levels in the medial prefrontal cortex of healthy pregnant women compared to non-pregnant controls

Psychoneuroendocrinology. 2021 Nov:133:105382. doi: 10.1016/j.psyneuen.2021.105382. Epub 2021 Aug 8.

Abstract

Very little is known about maternal cerebral changes during pregnancy. Since there is an increased risk for major depression during pregnancy and postpartum, it is important to understand the structural and neurochemical changes that occur in the brain during pregnancy. Using proton magnetic resonance spectroscopy (1H-MRS) (3 T field strength), glutamate (Glu) levels were measured in the medial prefrontal cortex (MPFC) of 21 healthy gravid subjects 2-3 weeks before their due date (6.74 ± 1.39), and in 14 non-pregnant healthy controls during their follicular phase (8.53 ± 1.55). Water quantified MPFC Glu levels were decreased in pregnant women (p < 0.01). We also observed a 13.9% decrease in percentage grey matter (%GM) (p < 0.01) in our MPFC voxel. As Glu is mostly found in GM, we repeated the statistical analysis after adjustment for %GM and found that the difference in Glu levels was no longer statistically significant when adjusted for %GM (p = 0.10). This investigation is the only systematic direct investigation of brain tissue composition and Glu levels in pregnant women. The main finding of this investigation is the decreased %GM in healthy pregnant women compared to non-pregnant women. These findings of decreased %GM in pregnancy may be responsible for the frequent complaints by pregnant women of cognitive difficulties also described as pregnesia.

Keywords: Depression; Glutamate; Grey matter; Magnetic resonance spectroscopy; Prefrontal cortex; Pregnancy; Pregnesia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Female
  • Glutamic Acid* / metabolism
  • Humans
  • Prefrontal Cortex* / metabolism
  • Pregnancy
  • Pregnant Women
  • Proton Magnetic Resonance Spectroscopy

Substances

  • Glutamic Acid